Junji Furuse

Junji Furuse

UNVERIFIED PROFILE

Are you Junji Furuse?   Register this Author

Register author
Junji Furuse

Junji Furuse

Publications by authors named "Junji Furuse"

Are you Junji Furuse?   Register this Author

100Publications

3256Reads

43Profile Views

Feasibility of Continuous Geriatric Assessments as a Prognostic Indicator in Elderly People with Gastrointestinal Cancer.

Intern Med 2019 Sep 3. Epub 2019 Sep 3.

Department of Medical Oncology, Kyorin University Faculty of Medicine, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.2856-19DOI Listing
September 2019

Paradigm Shifting of Systemic Chemotherapy for Unresectable Pancreatic Cancer in Japan.

Authors:
Junji Furuse

J Clin Med 2019 Aug 4;8(8). Epub 2019 Aug 4.

Department of Medical Oncology, Kyorin University Faculty of Medicine, 6-20-2, Shinkawa, Mitaka-Shi, Tokyo 181-8611, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/jcm8081170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722607PMC
August 2019

[Patient and Public Involvement for Cancer Treatments-Physicians' Perspectives].

Gan To Kagaku Ryoho 2019 Aug;46(8):1230-1234

Dept. of Medical Oncology, Kyorin University Faculty of Medicine.

View Article

Download full-text PDF

Source
August 2019

A PARP inhibitor in pancreatic cancer: Enhancement anti-tumour activity of chemoradiation therapy against pancreatic cancer?

Authors:
Junji Furuse

EBioMedicine 2019 Feb 28;40:9-10. Epub 2019 Jan 28.

Department of Medical Oncology, Kyorin University Faculty of Medicine, Japan. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ebiom.2019.01.039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413480PMC
February 2019

Feasibility study of postoperative adjuvant chemotherapy with S-1 in patients with biliary tract cancer.

Int J Clin Oncol 2018 Oct 28;23(5):894-899. Epub 2018 Apr 28.

Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, 8-1, Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-018-1283-6DOI Listing
October 2018

An early clinical trial of Salirasib, an oral RAS inhibitor, in Japanese patients with relapsed/refractory solid tumors.

Cancer Chemother Pharmacol 2018 09 10;82(3):511-519. Epub 2018 Jul 10.

Department of Medical Oncology, Kindai University Faculty of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3618-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6105164PMC
September 2018

APC:T1556fs and STK11 mutations in duodenal adenomas and adenocarcinomas.

Surg Today 2018 Aug 10;48(8):765-772. Epub 2018 Mar 10.

Department of Surgery, Kyorin University School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo, 181-8611, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00595-018-1649-4DOI Listing
August 2018

New developments in systemic therapy for advanced biliary tract cancer.

Jpn J Clin Oncol 2018 Aug;48(8):703-711

Department of Medical Oncology, Faculty of Medicine, Kyorin University, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyy082DOI Listing
August 2018

A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer.

Cancer Chemother Pharmacol 2018 06 9;81(6):1017-1023. Epub 2018 Apr 9.

Department of Medical Oncology, Kyorin University School of Medicine, 6-20-2, Shinkawa, Mitaka, Tokyo, 181-8611, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-018-3577-9DOI Listing
June 2018

Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer.

J Hepatobiliary Pancreat Sci 2018 May 12;25(5):261-268. Epub 2018 Apr 12.

Faculty of Medicine, Department of Surgery, Kyorin University, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jhbp.547DOI Listing
May 2018

Clinical Practice Guidelines for Pancreatic Cancer 2016 From the Japan Pancreas Society: A Synopsis.

Pancreas 2017 May/Jun;46(5):595-604

From the *Clinic of Fukuoka Government Building, Hamanomachi Hospital, Fukuoka; †Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital; ‡Department of Gastroenterology, Tokyo Women's Medical University; §Department of Medical Oncology, Faculty of Medicine, Kyorin University; ∥Department of Radiation Oncology, National Cancer Center Hospital, Tokyo; ¶Department of Gastroenterology, JA Onomichi General Hospital, Onomichi; #Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai; and **Department of Gastroenterology and Hepatology, Kansai Medical University, Hirakata, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000816DOI Listing
March 2018

The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer.

Anticancer Res 2018 03;38(3):1755-1761

Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.12412DOI Listing
March 2018

Chemotherapy for hepatocellular carcinoma: current status and future perspectives.

Jpn J Clin Oncol 2018 Feb;48(2):103-114

Department of Medical Oncology, Kyorin University School of Medicine, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyx180DOI Listing
February 2018

[The Risk Factors of Cancer Chemotherapy in Elderly Patients].

Gan To Kagaku Ryoho 2018 Jan;45(1):8-11

Dept. of Medical Oncology, Kyorin University Faculty of Medicine.

View Article

Download full-text PDF

Source
January 2018

Up to date of chemotherapy for pancreatic cancer.

Authors:
Junji Furuse

Nihon Shokakibyo Gakkai Zasshi 2017 ;114(4):637-643

Department of Medical Oncology, Kyorin University Faculty of Medicine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.11405/nisshoshi.114.637DOI Listing
October 2017

[Treatments for Pancreatic Cancer with Oligometastasis].

Authors:
Junji Furuse

Gan To Kagaku Ryoho 2017 Oct;44(10):827-830

Dept. of Medical Oncology, Kyorin University Faculty of Medicine.

View Article

Download full-text PDF

Source
October 2017

Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 Cases.

Anticancer Res 2017 07;37(7):3711-3715

Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11743DOI Listing
July 2017

Efficacy and safety of gemcitabine plus S-1 in pancreatic cancer: a pooled analysis of individual patient data.

Br J Cancer 2017 Jun 4;116(12):1544-1550. Epub 2017 May 4.

Department of Management Science, Tokyo University of Science, 6-3-1 Niijuku, Katsushika-ku, Tokyo 125-8585, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518857PMC
June 2017

Emerging protein kinase inhibitors for treating pancreatic cancer.

Expert Opin Emerg Drugs 2017 03 17;22(1):77-86. Epub 2017 Feb 17.

a Department of Medical Oncology , Kyorin University, Faculty of Medicine , Tokyo , Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728214.2017.1293648DOI Listing
March 2017

[Geriatric Oncology].

Gan To Kagaku Ryoho 2017 Feb;44(2):97-101

Dept. of Medical Oncology, Kyorin University Faculty of Medicine.

View Article

Download full-text PDF

Source
February 2017

Safety and efficacy of sorafenib in Japanese patients with hepatocellular carcinoma in clinical practice: a subgroup analysis of GIDEON.

J Gastroenterol 2016 Dec 22;51(12):1150-1160. Epub 2016 Apr 22.

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-016-1204-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121182PMC
December 2016

Integrative biomarker analyses indicate etiological variations in hepatocellular carcinoma.

J Hepatol 2016 08 27;65(2):296-304. Epub 2016 Apr 27.

Novartis Institutes for Biomedical Research, Cambridge, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2016.04.015DOI Listing
August 2016

A comparison of four methods for detecting mutations in formalin-fixed specimens from metastatic colorectal cancer patients.

Oncol Lett 2016 Jul 16;12(1):150-156. Epub 2016 May 16.

Division of Medical Oncology, Department of Internal Medicine, Showa University Hospital, Hatanodai, Shinagawa, Tokyo 142-8666, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2016.4576DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906624PMC
July 2016

TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.

Radiology 2016 May 8;279(2):630-40. Epub 2016 Jan 8.

From Vascular and Interventional Radiology, Johns Hopkins University School of Medicine, 600 N Wolfe St, Blalock 545, Baltimore, MD 21287 (J.F.G.); Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka, Japan (M.K.); Department of Internal Medicine, Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Tex (J.A.M.); University of California-San Francisco, San Francisco, Calif (A.P.V.); Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China (X.P.C.); Department of Gastroenterology and Hepatology, INSERM U954, University Hospital, University of Lorraine, Nancy, France (J.P.B.); Policlínica Metropolitana, Caracas, Venezuela (L.D.); Kyorin University School of Medicine, Mitaka, Tokyo, Japan (J.F.); Hospital Angeles Clínica Londres, Mexico City, Mexico (L.L.d.G.); University Hospital of Larissa, Larissa, Greece (C.P.); Virginia Commonwealth University Medical Center, Richmond, Va (A.J.S.); Department of Digestive Surgery, Nihon University School of Medicine, Tokyo, Japan (T.T.); Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China (S.L.Y.); The Catholic University of Korea, Seoul, Korea (S.K.Y.); Global Medical Affairs, Bayer Healthcare Pharmaceuticals, Whippany, NJ (K.N.); Clinical Statistics, Bayer Healthcare Pharmaceuticals, Whippany, NJ (R.L.); Global Medical Affairs and Pharmacovigilance, Bayer Pharma AG, Berlin, Germany (S.H.); and Division of Diagnostic Imaging and Intervention, Pisa University Hospital and School of Medicine, Pisa, Italy (R.L.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2015150667DOI Listing
May 2016

Phase I/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer.

Cancer Chemother Pharmacol 2016 Mar 3;77(3):595-603. Epub 2016 Feb 3.

Department of Medical Oncology, Kyorin University School of Medicine, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-2972-3DOI Listing
March 2016

[Adjuvant Chemotherapy after Surgery for Pancreatic Cancer].

Authors:
Junji Furuse

Gan To Kagaku Ryoho 2016 Feb;43(2):160-4

Dept. of Medical Oncology, Kyorin University School of Medicine.

View Article

Download full-text PDF

Source
February 2016

Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version).

Hepatol Res 2016 Jan 4;46(1):3-9. Epub 2015 Aug 4.

Committee for Response Evaluation Criteria in Cancer of the Liver, Liver Cancer Study Group of Japan, Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama, Japan.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/hepr.12542
Publisher Site
http://dx.doi.org/10.1111/hepr.12542DOI Listing
January 2016

Multicenter cooperative case survey of hepatitis B virus reactivation by chemotherapeutic agents.

Hepatol Res 2015 Dec 2;45(12):1220-7. Epub 2015 Mar 2.

Department of Medical Oncology and Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.12496DOI Listing
December 2015

Microarray Analysis of Gene Expression at the Tumor Front of Colon Cancer.

Anticancer Res 2015 Dec;35(12):6577-81

Department of Pathology, Kyorin University Hospital, Mitaka, Tokyo, Japan.

View Article

Download full-text PDF

Source
December 2015

[Chemoradiotherapy for Locally Advanced Pancreatic Cancer].

Gan To Kagaku Ryoho 2015 Oct;42(10):1152-5

Dept. of Internal Medicine, Medical Oncology, School of Medicine, Kyorin University.

View Article

Download full-text PDF

Source
October 2015

Characterization of patients with advanced pancreatic cancer and high serum interleukin-6 levels.

Pancreas 2015 Jul;44(5):756-63

From the *Department of Hepatobiliary and Pancreatic Oncology, †Department of Palliative Medicine, and ‡Pathology Division, Research Center for Innovative Oncology, National Cancer Center Hospital East, Kashiwa; §Department of Medical Oncology, Kyorin University School of Medicine, Mitaka; ∥Center for Suicide Prevention, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira; and ¶Chugai Pharmaceutical Co, Ltd, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000335DOI Listing
July 2015

[Systemic chemotherapy for unresectable pancreatic cancer].

Nihon Rinsho 2015 Mar;73 Suppl 3:148-51

View Article

Download full-text PDF

Source
March 2015

[Current status and future perspective of chemotherapy for gallbladder cancer].

Nihon Rinsho 2015 Mar;73 Suppl 3:585-9

View Article

Download full-text PDF

Source
March 2015

[Activity of the JCOG geriatric study committee and chemotherapy of colorectal cancer in older patients].

Gan To Kagaku Ryoho 2015 Jan;42(1):16-20

Dept. of Medical Oncology, Kyorin University School of Medicine.

View Article

Download full-text PDF

Source
January 2015

Phase II study of FOLFIRINOX for chemotherapy-naïve Japanese patients with metastatic pancreatic cancer.

Cancer Sci 2014 Oct 29;105(10):1321-6. Epub 2014 Sep 29.

Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462360PMC
October 2014

EBM-based Clinical Guidelines for Pancreatic Cancer (2013) issued by the Japan Pancreas Society: a synopsis.

Jpn J Clin Oncol 2014 Oct 8;44(10):883-8. Epub 2014 Sep 8.

Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyu127DOI Listing
October 2014

Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system.

Cancer Sci 2014 Sep 6;105(9):1176-81. Epub 2014 Sep 6.

Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital, Tokyo, Japan; Department of Biostatics and Epidemiology, Graduate School of Medicine, Yokohama City University, Kanagawa, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12473DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4462387PMC
September 2014

Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.

JAMA 2014 Jul;312(1):57-67

National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan19National Cheng Kung University Hospital, Tainan, Taiwan20Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2014.7189DOI Listing
July 2014

Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma.

Jpn J Clin Oncol 2014 Jun 21;44(6):570-8. Epub 2014 Apr 21.

Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyu045DOI Listing
June 2014

Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics.

Invest New Drugs 2014 Feb 4;32(1):104-12. Epub 2013 Apr 4.

International Medical Center-Comprehensive Cancer Center, Saitama Medical University, 1397-1 Yamane, Hidaka, Saitama, 350-1298, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-013-9953-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913857PMC
February 2014

[Current status and future directions of chemotherapy for pancreatic cancer].

Authors:
Junji Furuse

Nihon Shokakibyo Gakkai Zasshi 2013 Dec;110(12):2060-5

Department of Medical Oncology, Kyorin University School of Medicine.

View Article

Download full-text PDF

Source
December 2013

Randomized phase II study of gemcitabine plus S-1 versus S-1 in advanced biliary tract cancer: a Japan Clinical Oncology Group trial (JCOG 0805).

Cancer Sci 2013 Sep 25;104(9):1211-6. Epub 2013 Jul 25.

Hepatobiliary and Pancreatic Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/cas.12218DOI Listing
September 2013

A multicenter phase II study of S-1 for gemcitabine-refractory biliary tract cancer.

Cancer Chemother Pharmacol 2013 May 24;71(5):1141-6. Epub 2013 Mar 24.

Department of Internal Medicine, Medical Oncology, Kyorin University School of Medicine, 6-20-2, Shinkawa, Mitaka, Tokyo 181-8611, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2106-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636435PMC
May 2013

Current status and future direction of chemotherapy for pancreatic cancer.

Chin Clin Oncol 2013 Mar;2(1)

Department of Medical Oncology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://www.thecco.net/article/view/1188
Publisher Site
http://dx.doi.org/10.3978/j.issn.2304-3865.2012.11.04DOI Listing
March 2013

The Hepatobiliary and Pancreatic Oncology (HBPO) Group of the Japan Clinical Oncology Group (JCOG): history and future direction.

Jpn J Clin Oncol 2013 Jan 24;43(1):2-7. Epub 2012 Oct 24.

Department of Internal Medicine, Medical Oncology, Kyorin University School of Medicine, 6-20-2, Shinkawa, Mitaka, Tokyo 181-8611, Japan.

View Article

Download full-text PDF

Source
https://academic.oup.com/jjco/article-lookup/doi/10.1093/jjc
Publisher Site
http://dx.doi.org/10.1093/jjco/hys177DOI Listing
January 2013